ONCOLYZE
Oncolyze is developing a disruptive technology for the treatment of cancer.
ONCOLYZE
Social Links:
Industry:
Biotechnology Health Care
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.oncolyze.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag Nginx Cloudflare JS
Similar Organizations
California Cardiac Solutions
California Cardiac Solutions develop novel disruptive technology to treat heart failure.
CytoSolv
CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.
Mitovation
Mitovation is developing novel infrared light (IRL) technology for the treatment of ischemic brain injuries.
Current Advisors List
Official Site Inspections
http://www.oncolyze.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.56 K
- Host name: vps67923.inmotionhosting.com
- IP address: 104.247.79.136
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Oncolyze"
Treating cancer by exploding cancer cells | Oncolyze
We are Oncolyze, a pre-clinical stage biopharmaceutical company that is developing a class of therapeutics to treat cancer in a new and disruptive way. What may just sound like a cool …See details»
Oncolyze - Crunchbase Company Profile & Funding
Organization. Oncolyze . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Oncolyze is developing a disruptive technology …See details»
OncoLize
Pharma-tech OncoLize is pitching its recent successes in pre-clinical pancreatic cancer treatment at RESI (4-6 September), PODD (28-29 October) and Bio-Europe (4-6 November) to complete its seed round with €1.5 million in order to …See details»
Oncolyze Company Profile | Management and Employees List
Oncolyze Profile and History. Oncolyze is developing a disruptive technology for the treatment of cancer. Our novel approach uses a simple mechanism of action to selectively kill cancer cells …See details»
Oncolyze, Inc. Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Oncolyze, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Oncolyze - Overview, News & Similar companies | ZoomInfo.com
Apr 5, 2023 Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Acute Myeloid Leukemia NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncolyze, …See details»
Oncolyze Company Profile 2024: Valuation, Funding & Investors
Oncolyze General Information Description. Provider of biotherapeutics services intended to treat cancer. The company develops anti-cancer drugs that combine suitably well with …See details»
Oncolyze - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Oncolyze . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. ... Oncolyze has 5 board …See details»
Oncolyze - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Oncolyze, a Company Aiming to Treat Cancer by Exploding
Aug 23, 2022 Oncolyze is developing a disruptive technology for the treatment of cancer. The drug's novel approach uses a simple mechanism of action to selectively kill cancer cells and …See details»
Treating cancer by exploding cancer cells | Oncolyze
Oncolyze is developing what we hope to be a transformational approach to cancer treatment. It all starts with a molecule called HDM2 (human double minute-binding protein-2). This is a protein …See details»
Oncolyze - Company Profile - Tracxn
Oncolyze - Provider of biotherapeutics for treating cancer. Raised funding from 2 investors. Oncolyze has 2858 competitors.See details»
Oncolyze Announces FDA Orphan Drug Designation for OM-301 …
Jan 5, 2022 Oncolyze Logo Oncolyze Logo NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncolyze, Inc, a biotech developing a disruptive technology for the treatment of cancer, today …See details»
Oncolyze Announces FDA Orphan Drug Designation for OM-301
Jan 5, 2022 Oncolyze is developing a disruptive technology for the treatment of cancer. Our novel approach uses a simple mechanism of action to selectively kill cancer cells and cancer …See details»
Oncolyze - Updates, News, Events, Signals & Triggers - Crunchbase
Oncolyze is developing a disruptive technology for the treatment of cancer.See details»
Treating cancer by exploding cancer cells | Oncolyze
In early 2022, Oncolyze announced that the U.S. Food and Drug Administration (FDA) granted the company orphan drug designation for OM-301 for the treatment of acute myeloid leukemia …See details»
FDA Grants Orphan Drug Designation to Novel Fusion Peptide in …
Apr 14, 2023 Pipeline. Oncolyze. Accessed April 14, 2023. bit.ly/404cHM9 “Not your grandfather’s HDM2.” Oncolyze. Accessed April 14, 2023. bit.ly/41vmHza; Oncolyze …See details»
Oncolyze, a Company Aiming to Treat Cancer by Exploding Cancer …
Aug 23, 2022 Oncolyze has launched a Regulation A+ ("Reg A") funding campaign to spread awareness of OM-301 among cancer patients, healthcare professionals, and the investment …See details»